Evaluation of the incidence of peri-stent myocardial infarction and determining predictive risk factors in patients undergoing elective angioplasty referring to heshmat hospital in rasht

Mahboobeh Gholipour, Arsalan Salari, Abbas Dolatpanah, Sanaz Vahdati, Salman Nikfarjam, Tolou hasandokht, Marjan Mahdavi Roshan, Sara Vahdati

Abstract


Introduction & Objective: Percutaneous Coronary Intervention (PCI (can be associated with a small but significant number of symptoms around procedure such as: myocardial infarction, thrombosis, stroke, broad bleeding or death, that among these symptoms, infarction around the procedure is the most common symptom. Therefore, the aim of this study was assessing the incidence of myocardial infarction around the stent and determining the predictive and preventive factors for this symptom. Method: 442 patients based on the previous angiography were candidates for elective PCI. Demographic, laboratory, and angiographic variables and their relationship with the peri-procedure infarction were investigated. Previous ck-MB and 8 and 24 hours were measured. Items that had at least three-time increase from the upper normal limit were considered as PMI. Results: Out of 442 patients with coronary PCI, 40 cases had CK-MB increase  three-times more than the increase in URL (9.44%). 149 (33.7%) were female and 293 (66.3%) were male. Patients with a history of hyperlipidemia and low LVEF, low GFR and high Cr, high CRP, high ureic acid, no or low dose of statin, metformin (in diabetics), more stent, longer lesion length, more balloon sessions, were more likely to suffer from PMI. Conclusion: Caring for renal function and administering adequate doses of statin and minimizing the number of balloon sessions can reduce the risk of post-PCI infarction.


Keywords


Myocardial Infarction, Percutaneous Coronary Intervention, Myocardial Infarction peri-Angioplasty.

Full Text:

PDF

References


last J, cummigs S. One year survival in acute myocardial infarction. Lancet 1993; 341:72-75.

R Sadykova, B Turlybekov, U Kanseitova, K Tulebayeva. (2018). Analysis of research on Foreign Language Translations of the Epopee «The Path of Abay» Opción, Año 33, No. 85 (2018): 362-373.

Peltonen M, Lundberg V, Huhtasaari F, Asplund K. Marked improvement in survival after acute myocardial infarction in middle-aged men but not in women. The Northern Sweden MONICA study 1985-94. J Intern Med 2000; 247(5):579-587.

Braunwald’s heart disease: a textbook of cardiovascular medicine / edited by Douglas L. Man Douglas P. Zipes, Peter Libby, Robert O. Bonow, Eugene Braunwald.—10th edition2015.

Duk-Woo Park, Young-Hak Kim ,Sung-Cheol Yun et al,Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention European Heart Journal (2013)34, 1662–1669.

Hanan Idris, MB ChB, Sidney Lo, MBBS, Ibrahim M. Shugman, MBBCh, PhD, Yousef Saad, MBBCh, Andrew P, and et al. Varying Definitions for Periprocedural Myocardial Infarction AlterEvent Rates and Prognostic Implication. J Am Heart Assoc. 2014 Dec; 3(6): e001086.

Ae-Young Her, Kyoung-Im Cho, Gillian Balbir Singh, Scot Garg, Yong Hoon Kim1, Bon-Kwon Koo5, and Eun-Seok Shin3A Comparison of Peri-Procedural Myocardial Infarction between Paclitaxel-Coated Balloon and Drug-Eluting Stent on De Novo Coronary Lesions. Yonsei Med J 2017 Jan; 58(1):99-10.

Monica Verdoia,LuciaBarbieri, AlonSchaffer,et al, Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: Journal of Thrombosis and Thrombolysis April 2014, Volume 37, Issue 3, pp 345-352.

SoichiroKumagai,Hideki Ishii, Tetsuya Amano et al: Impact of chronic kidney disease on the incidence of peri-procedural myocardial injury in patients undergoing elective stent implantation: Nephrol Dial Transplant (2012) 27: 1059–1063.

JVV Antúnez (2016). Hipótesis para un derecho alternativo desde la perspectiva latinoamericana. Opción 32 (13), 7-10.

Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction.Carlo Briguori, MD, PhD?,†; Gabriella Visconti, MD?; Amelia Focaccio, MD?; Bruno Golia, MD?; Alaide Chieffo, MD†; Alfredo Castelli, MD†; Marco Mussardo, MD†; Matteo Montorfano, MD†; Bruno Ricciardelli, MD?; Antonio Colombo, MD.2009 AUG6.

Effect of high dose statin pretreatment on the incidence of periprocedural MI in patient undergoing PCI;Chuan Nan Zhai, MD;Hong Liang Cong;YuJie Liu.2015

John W. Calvert. Treating Percutaneous Coronary Intervention-Related Myocardial Injury with Metformin. Cardiology. 2014; 127(2): 130–132.

Gruntzig A, Myler R, Hanna E, et al: Transluminal angioplasty of coronary artery stenosis. Circulation 1977; 56:84.

, King SB 3rd, Schlumpf M: Ten-year completed follow-up of percutaneous transluminal coronary angioplasty: the early Zurich experience. J Am Coll Cardiol 1993; 22: 353-360.

Nagimovich B.N., Nasimovna K.C., Peculiarities of consumer innovations and the necessity of formation of management tools, oriented for the future consumer, Astra Salvensis - review of history and culture, No. 10, 2017, p. 167-177.

Lysanov D.M., Karamyshev A.N., Eremina I.I., Comparative evaluation of quality characteristics of process equipment, Astra Salvensis - review of history and culture, No. 10, 2017, p. 217-223.


Refbacks

  • There are currently no refbacks.




Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Revista Publicando.

Licencia de Creative Commons

 

This Content is available under licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional.